董事
Hongbo Lu, Ph.D., MBA is a seasoned healthcare investor and independent director serving on the boards of several public biopharma companies, including Zenas BioPharma, Inc. (Nasdaq: ZBIO) since 2022, where she recently purchased 263,160 shares on October 7, 2025, for approximately $5 million.[[5]](https://www.quiverquant.com/news/Insider+Purchase:+Director+at+$ZBIO+Buys+263,160+Shares)[[1]](https://fintool.com/app/research/companies/ARWR/people/hongbo-lu)[[4]](https://www.nasdaq.com/market-activity/insiders/lu-hongbo-1077521) She also serves as a director at Terns Pharmaceuticals, Inc. (Nasdaq: TERN) since 2020 and joined Arrowhead Pharmaceuticals, Inc. (Nasdaq: ARWR) as an independent director in March 2024, contributing to the Science, Nomination, and Compensation Committees.[[1]](https://fintool.com/app/research/companies/ARWR/people/hongbo-lu)[[2]](https://arrowheadpharma.com/about/leadership-team/hongbo-lu/)[[6]](https://app.boardroomalpha.com/profiles/people/A1112719-HONGBO_LU)
Dr. Lu brings over 20 years of experience in healthcare investment, having held key roles such as Managing Partner at Vivo Capital LLC (since December 2020), Managing Partner at Lilly Asia Ventures (2017–2020), and Managing Director at OrbiMed Advisors.[[1]](https://fintool.com/app/research/companies/ARWR/people/hongbo-lu)[[2]](https://arrowheadpharma.com/about/leadership-team/hongbo-lu/) She is a founding member of NEXTBio Capital and has served on more than 20 biopharma boards, including past positions at Turning Point Therapeutics and Avedro.[[2]](https://arrowheadpharma.com/about/leadership-team/hongbo-lu/) Her career began as a biotech analyst at Piper Jaffray & Co. and involved early-stage biotech operations.[[2]](https://arrowheadpharma.com/about/leadership-team/hongbo-lu/) Dr. Lu holds a Ph.D. in Bioengineering from the University of Washington, an MBA from UC Berkeley Haas School of Business, and is an honors graduate of Tsinghua University.[[1]](https://fintool.com/app/research/companies/ARWR/people/hongbo-lu)[[2]](https://arrowheadpharma.com/about/leadership-team/hongbo-lu/)
查看完整内部人档案 →